항균성 중앙 정맥 카테터의 소개
-
2022-07-28
-
LEPU
Lepu's Antimicrobial Central Venous Catheter is the first medicated central venous catheter market in China. Since its official launch in 2008, it has been used in millions of clinical cases.
Why It Is Recommended To Use Antimicrobial Central Venous Catheter?
In clinical practice, 중앙 정맥 카테터 키트 is commonly used to rescue critically ill patients with severe shock, dehydration, blood loss, and hypovolemia. Monitoring of central venous pressure can guide clinicians in diagnosing and treating patients, so it is often necessary to retain or prolong the indwelling time of the catheter.
However, the operation time of central venous puncture is short, the patient's body resistance is low, immunity is weak, and trauma is large. With the widespread use of central venous catheters, the consequent infection rate has increased significantly, and the mortality rate of patients has increased. Clinically, central venous catheters have been listed as a common source of infection, so the choice of an Antimicrobial Central Venous Catheter with a bacteriostatic effect can reduce the incidence of infection in patients.

Lepu 의료 항균 중앙 정맥 카테터의 장점 및 장점
The disposable Antimicrobial Central Venous Catheter produced by Lepu 의료 장비 제조 업체 is based on the traditional central venous catheter and is coated with two antibiotics, rifampicin and minocycline hydrochloride. Among them, rifampicin is a semi-synthetic broad-spectrum antibacterial drug of rifampicin. It has an inhibitory effect on aerobic gram-positive bacteria and aerobic gram-negative bacteria. Minocycline Hydrochloride is a semi-synthetic tetracycline broad-spectrum antibiotic with high efficacy and long-term effect. It has an inhibitory effect on Staphylococcus aureus, Streptococcus, etc., and Gram-negative bacteria. Combining these two drugs produces a complementary antibacterial effect, which can achieve an excellent antibacterial effect. It has been documented that the drug CVC can reduce the incidence of CRABSI by 90%.
Lepu Medical's 중요 관리 제품 like the Antimicrobial Central Venous Catheter is available in various sizes and is suitable for different types of patients, providing more options for doctors. The connection between the catheter and the extension tube adopts the patented technology, which has solved the leakage and seepage problems of similar products on the market.
약용 중앙 정맥 카테터의 임상 적 사용은 환자의 감염 발생률을 크게 줄일 수 있으며 이는 전염성 합병증 및 불필요한 의학적 분쟁을 예방하기위한 새로운 예방 조치이기도합니다. Lepu가 생산 한 항균 중앙 정맥 카테터는 우수한 디자인, 안전성, 효과, 광범위한 항균 스펙트럼, 긴 항균 시간, 알레르기 반응 없음, 전신 항생제의 적용주기를 줄일 수 있으며 임상 적용 가치가 높습니다.
자세한 정보:https://en.lepumedical.com/products/safecath-plus-antimicrobial-central-venous-catheter-kit/
